TMS CoTSE:4891 -0.96%32 Market Cap is 円4,693.27 Mil as of Jul. 09, 2026. GuruFocus rates TSE:4891 with a GF Score™ of 32/100. The stock has 1 warning sign investors should review. Among 1,421 Biotechnology companies, TMS Co ranks worse than 71.85% on this metric.
Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). TMS Co's share price for the quarter that ended in Dec. 2025 was 円129. TMS Co's Shares Outstanding (EOP) for the quarter that ended in Dec. 2025 was 45.49 Mil. Therefore, TMS Co's market cap for the quarter that ended in Dec. 2025 was 円5,867.69 Mil.
TMS Co's quarterly market cap
increased
from May. 2025 (円7,143.84 Mil) to Aug. 2025 (円7,232.27 Mil) but then
declined
from Aug. 2025 (円7,232.27 Mil) to Dec. 2025 (円5,867.69 Mil).
TMS Co's annual market cap
declined
from Feb. 2023 (円22,676.50 Mil) to Feb. 2024 (円13,098.80 Mil) and
declined
from Feb. 2024 (円13,098.80 Mil) to Feb. 2025 (円8,267.65 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. TMS Co's Enterprise Value for Today is 円1,912.24 Mil.
TMS Co (TSE:4891) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
TMS Co Market Cap Related Terms
TMS Co Market Cap Historical Data
* Premium members only.
The historical data trend for TMS Co's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TSE:4891 vs VRTX, REGN, ALNY: Market Cap Comparison
For the Biotechnology subindustry, TMS Co's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
TMS Co Market Cap vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, TMS Co's Market Cap distribution charts can be found below:
* The bar in red indicates where TMS Co's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
TMS Co's Market Cap for the fiscal year that ended in Feb. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TMS Co (TSE:4891) has a Market Cap of 円4,693.27 Mil as of Jul. 09, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on TMS Co and its competitors. According to the industry distribution chart, TMS Co ranks #1021 out of 1421 companies in the Biotechnology industry, placing it in the top 71.9%.
Is TMS Co's Market Cap too high?
TMS Co's current Market Cap is 円4,693.27 Mil. Based on the distribution chart, TMS Co ranks #1021 out of 1421 companies in the Biotechnology industry, which is below the industry midpoint. Overall, TMS Co has a GF Score™ of 32/100, reflecting its overall financial health beyond just this single metric.
How does TMS Co's Market Cap compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, TMS Co ranks #1021 out of 1421 companies for Market Cap. This places TMS Co in the lower half of its industry. The industry median Market Cap is 119.86. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Biotechnology company?
The median Market Cap among Biotechnology companies is 119.86, based on 1,421 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on TMS Co and its competitors. For the Biotechnology industry, the median Market Cap is 119.86 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. TMS Co's current Market Cap is 円4,693.27 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is TMS Co stock overvalued right now?
TMS Co (TSE:4891) has a current Market Cap of 円4,693.27 Mil. The current Market Cap is 円4,693.27 Mil. TMS Co's overall GF Score™ is 32/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For TMS Co (TSE:4891), the current Market Cap is 円4,693.27 Mil as of Jul. 09, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
TMS Co Ltd is focused on researching, developing, manufacturing, and selling pharmaceuticals. The company is involved in conducting research and development of SMTP compounds, which are drug candidate substances targeting soluble epoxide hydrolase (sEH), an enzyme found in the human body. It is developing sEH inhibitors for various inflammatory diseases. The company's clinical pipeline comprises three compounds: TMS-007 (being developed as a potential treatment for acute cerebral infarction), which is in the late clinical stage, TMS-010, and JX09 (for resistant and poorly controlled hypertension) and TMS-008 (to target acute inflammatory diseases such as kidney injury and cancer cachexia), which are in the early clinical stage. In addition, it has TMS-009 as a backup compound for TMS-008.
32GF Score
Get the complete analysis for TSE:4891
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:4891 has been successfully added to your 
